Skip to main content
OpenTrials

Clinical trial condition

Multiple Myeloma

Explore clinical trials studying Multiple Myeloma. Study availability and eligibility vary by location and protocol.

1,661 public trials 322 recruiting studies
Refine in advanced search Browse all conditions

Multiple Myeloma trial results

Completed

Upfront Chimeric Antigen Receptor T-Cell to Upgrade Response in Multiple Myeloma

NCT05032820

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • City of Hope National Medical Center Duarte, California, United States
  • Stanford Hospital and Clinics Palo Alto, California, United States
  • University of California, San Francisco San Francisco, California, United States
  • H. Lee Moffitt Cancer Center Tampa, Florida, United States
View all 15 locations
View Trial Details
Completed

IFM2009-02-Pomalidomide and Dexamethasone Phase 2 Myeloma

NCT01053949

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • CHRU-Hôpital Sud, avenue Laennec, Amiens, France
  • Hématologie, Hôpital Avicenne Bobigny, France
  • Hématologie, CHU, avenue G.Clemenceau Caen, France
  • Hématologie Clinique, CHU, Hôpital d'Enfants Dijon, France
View all 19 locations
View Trial Details
Completed

ACP-196 (Acalabrutinib) in Combination With Pembrolizumab, for Treatment of Hematologic Malignancies

NCT02362035

Conditions
Blood Protein Disorders, Burkitt Lymphoma, CLL, +47 more
Locations
  • Research Site Tucson, Arizona, United States
  • Research Site Los Angeles, California, United States
  • Research Site Denver, Colorado, United States
  • Research Site Washington D.C., District of Columbia, United States
View all 19 locations
View Trial Details
Completed

IV Busulfan Plus Bortezomib Conditioning Regimen for Second Autologous Stem Cell Transplant in Multiple Myeloma Patients

NCT01009840

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Arizona Cancer Center Tucson, Arizona, United States
  • Blood and Marrow Transplant Group of Georgia Atlanta, Georgia, United States
  • Loyola University Medical Center Maywood, Illinois, United States
  • Indiana University Melvin and Bren Simon Cancer Center Indianapolis, Indiana, United States
View all 13 locations
View Trial Details
Completed

COM902 (A TIGIT Inhibitor) in Subjects With Advanced Malignancies

NCT04354246

Conditions
Adnexal Diseases, Advanced Cancer, Blood Protein Disorders, +53 more
Locations
  • Florida Cancer Specialists Sarasota, Florida, United States
  • Massachusetts General Hospital. Boston, Massachusetts, United States
  • START Midwest. Grand Rapids, Michigan, United States
  • The Ohio State University Comprehensive Cancer Center. Columbus, Ohio, United States
View Trial Details
Completed

Study to Investigate Alternative Dosing Regimens of Belantamab Mafodotin in Participants With Relapsed or Refractory Multiple Myeloma

NCT05064358

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +16 more
Locations
  • GSK Investigational Site West Palm Beach, Florida, United States
  • GSK Investigational Site Kansas City, Missouri, United States
  • GSK Investigational Site New York, United States
  • GSK Investigational Site Chattanooga, Tennessee, United States
View all 77 locations
View Trial Details

Related conditions